debrisoquin has been researched along with Substance Withdrawal Syndrome in 1 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Swann, AC | 1 |
| Elsworth, JD | 1 |
| Charney, DS | 1 |
| Jablons, DM | 1 |
| Roth, RH | 1 |
| Redmond, DE | 1 |
| Maas, JW | 1 |
1 other study available for debrisoquin and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Brain catecholamine metabolites and behavior in morphine withdrawal.
Topics: Animals; Behavior, Animal; Brain Chemistry; Catecholamines; Debrisoquin; Homovanillic Acid; Humans; | 1982 |